---
title: "TCT 2025: Coronary bioadaptor shows reduction in events compared to DES at two years"
date: "2025-10-27T21:22:58.000Z"
publishedDate: "27 octobre 2025"
summary: "Latest clinical results for the DynamX coronary bioadaptor (Elixir Medical) demonstrate that the device achieved a 48% reduction in target lesion failure (TLF)—encompassing reductions in cardiac death, target vessel myocardial infarction, and ischemia-driven target lesion revascularisation—from six months through two years in prespecified landmark superiority analysis. David Erlinge (Lund University, Lund, Sweden) presented the latest [&#8230;] The post TCT 2025: Coronary bioadaptor shows reduction in events compared to DES at two years appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/tct-2025-coronary-bioadaptor-shows-reduction-in-events-compared-to-des-at-two-years/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-10-27-tct-2025-coronary-bioadaptor-shows-reduction-in-events-compared-to-des-at-two-years"
imageUrl: "http://cardiovascularnews.com/wp-content/uploads/sites/14/2025/10/IMG_6376-scaled.jpeg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/tct-2025-coronary-bioadaptor-shows-reduction-in-events-compared-to-des-at-two-years/"
---

![TCT 2025: Coronary bioadaptor shows reduction in events compared to DES at two years](http://cardiovascularnews.com/wp-content/uploads/sites/14/2025/10/IMG_6376-scaled.jpeg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/tct-2025-coronary-bioadaptor-shows-reduction-in-events-compared-to-des-at-two-years/*

## L’essentiel

Latest clinical results for the DynamX coronary bioadaptor (Elixir Medical) demonstrate that the device achieved a 48% reduction in target lesion failure (TLF)—encompassing reductions in cardiac death, target vessel myocardial infarction, and ischemia-driven target lesion revascularisation—from six months through two years in prespecified landmark superiority analysis. David Erlinge (Lund University, Lund, Sweden) presented the latest [&#8230;] The post TCT 2025: Coronary bioadaptor shows reduction in events compared to DES at two years appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/tct-2025-coronary-bioadaptor-shows-reduction-in-events-compared-to-des-at-two-years/
